title: Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon.
authors.affiliation: Department of Histopathology, Bristol Royal Infirmary, Bristol, UK.
authors.forename: Usman
authors.initials: U
authors.lastname: Hassan
authors.affiliation: Department of Cellular Pathology, Southmead Hospital, Bristol, UK.
authors.forename: Behrang
authors.initials: B
authors.lastname: Mozayani
authors.affiliation: Department of Histopathology, Bristol Royal Infirmary, Bristol, UK.
authors.forename: Newton A C S
authors.initials: NA
authors.lastname: Wong
mesh_terms: D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D018278:Carcinoma, Neuroendocrine / Q000150:complications / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D005047:Etoposide / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D010984:Platinum / Q000627:therapeutic use; D017354:Point Mutation; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics; D014057:Tomography, X-Ray Computed
chemical_list: D000972:Antineoplastic Agents, Phytogenic; C117307:KRAS protein, human; D010984:Platinum; D005047:Etoposide; D016283:Proto-Oncogene Proteins p21(ras)